# An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD

> **NCT02259517** · NA · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 38 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Guanfacine
- **DRUG:** Lisdexamfetamine

## Key facts

- **NCT ID:** NCT02259517
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2021-11-06
- **Final completion:** 2021-11-06
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Recruitment/enrollment ended early due to the COVID-19 pandemic
- **Last updated:** 2023-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02259517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02259517, "An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02259517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*